LBO — MAYO CLINIC HEALTH SYS - NEW PRAGUE
IRR: 18.1% | MOIC: 2.30x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.1%
IRR
2.30x
MOIC
$63.8M
Entry EV
$101.9M
Exit EV
$32.8M
Equity Invested
Sources & Uses
S&UTotal · $63.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $24.8M | 38.8% | |
| Sub Debt | $6.2M | 9.7% | |
| Equity | $32.8M | 51.5% | |
| Enterprise Value | $61.9M | 97.1% | |
| Transaction Fees | $1.9M | 2.9% | |
| Total Uses | $63.8M | 100.0% |
Interpretation
INTAt 2.30x MOIC and 18.1% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $9.7M |
| Exit Ev | $101.9M |
| Net Debt At Exit | $26.4M |
| Equity At Exit | $75.4M |
| Equity Invested | $32.8M |
| Total Value Created | $42.6M |
| Value From Growth | $36.8M |
| Value From Multiple | $3.1M |
| Value From Deleveraging | $4.5M |